Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 152
interventional 125
Observational 26
Registry 1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Behavioral 64
Drug|placebo 16
Other 13
Device 7
Drug 6
Behavioral|Other 5
Behavioral|Device 3
Behavioral|Drug 3
Procedure 3
Behavioral|Drug|placebo 2
Device|Other 1
Drug|Other 1
Drug|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 43
NA 14
Germany 9
Canada 8
Denmark 7
France 6
Norway 6
Spain 5
Netherlands 4
Sweden 3
Switzerland 3
Australia 2
Mexico 2
United Kingdom 2
Australia|Austria|Norway 1
Austria|Germany 1
Chile|Germany|Switzerland 1
Czech Republic|Germany|Poland|Slovakia|United Kingdom 1
France|Switzerland 1
Germany|Switzerland 1
India 1
Italy 1
Taiwan 1
United States|Argentina|Poland|Romania|Turkey 1
United States|Belgium|France|Germany|Norway|Portugal|Spain|Sweden|United Kingdom 1

Sites per Study

Site_count Study_Count
1 102
2 9
3 5
5 5
11 1
14 1
15 1
39 1

Phase

Phase Study_Count
N/A 92
Phase 2 13
Phase 3 8
Phase 4 5
Phase 1/Phase 2 4
Phase 2/Phase 3 2
Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 18
2 82
3 9
4 3
6 1
7 1
8 1
NA 10

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 6.0000 84 15.00 30.00000 100 15.00 13.0
1st Qu. 45.0000 84 19.50 40.00000 125 78.75 20.0
Median 86.0000 84 30.00 60.00000 150 136.00 28.0
Mean 147.8427 84 46.75 80.61538 150 187.75 47.2
3rd Qu. 160.0000 84 57.25 99.00000 175 310.00 84.0
Max. 1912.0000 84 112.00 240.00000 200 450.00 91.0

Trial Group Type

group_type Group_Count
Experimental 116
Active Comparator 59
No Intervention 23
Placebo Comparator 22
Other 17
NA 10
Sham Comparator 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 87
Single Group Assignment 25
Crossover Assignment 10
NA 2
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 98
Basic Science 8
Health Services Research 6
Prevention 5
Other 4
NA 3
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
NA 6
United States 5
Canada 3
United Kingdom 3
France 2
Germany 2
Norway 2
Denmark 1
Netherlands 1
Spain 1

Sites per Study

Site_count Study_Count
1 24
2 1
3 1

Enrollment Metrics

Measure Observational
Min 9.0000
1st Qu 59.0000
Median 92.0000
Mean 733.1923
3rd Qu 516.7500
Max 10000.0000

Observation Model

observational_model Study_Count
Cohort 11
Case-Control 3
Case Control 3
NA 3
Case-Only 2
Other 2
Ecologic or Community 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 16
Cross-Sectional 5
Retrospective 3
Other 1
NA 1

Registries

Studies by Country

Country Study_Count
United Kingdom 1

Sites per Study

Site_count Study_Count
1 1

Enrollment Metrics

Measure Registries
Min 9500
1st Qu 9500
Median 9500
Mean 9500
3rd Qu 9500
Max 9500

Registry Model

observational_model Study_Count
Cohort 1

Time Perspective

time_perspective Study_Count
Cross-Sectional 1

Follow-up

target_duration Study_Count
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03408860 Isolating Mechanisms in the Treatment of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03408860 Active, not recruiting Boston University Charles River Campus 2020-09-30
NCT03407443 Pilot the Use of VA Make the Connection Campaign to Facilitate Help Seeking Among Vulnerable Veterans https://ClinicalTrials.gov/show/NCT03407443 Active, not recruiting Canandaigua VA Medical Center 2020-09-30
NCT02573246 Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study https://ClinicalTrials.gov/show/NCT02573246 Completed Duke University 2020-02-17
NCT03361826 Magnetic Seizure Therapy for the Treatment of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03361826 Recruiting Centre for Addiction and Mental Health 2020-12-31
NCT03329677 An 18-Month Psychotherapy of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03329677 Recruiting Weill Medical College of Cornell University 2021-01-31
NCT03295838 Outcomes of Mentalization-Based Treatment for Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03295838 Completed Karolinska Institutet 2014-05-03
NCT03191565 Using Smartphones for Selfmonitoring of Skill-use i Dialectical Behavior Therapy https://ClinicalTrials.gov/show/NCT03191565 Active, not recruiting Region of Southern Denmark 2019-12-30
NCT03190707 A Good Start to Life - an Early Cross-sectorial Intervention https://ClinicalTrials.gov/show/NCT03190707 Completed Intersectoral Research Unit for Health Services 2020-01-31
NCT03180541 Evaluating the Coordinated National Implementation of DBT in Ireland https://ClinicalTrials.gov/show/NCT03180541 Completed Health Service Executive, Ireland 2017-09-30
NCT03166579 Effectiveness Evaluation of ‘The Endeavour Programme’ https://ClinicalTrials.gov/show/NCT03166579 Completed Health Service Executive, Ireland 2016-08-31
NCT03123198 Dialectical Behavior Therapy Rutgers University Research Program https://ClinicalTrials.gov/show/NCT03123198 Recruiting Rutgers, The State University of New Jersey 2025-03-31
NCT03028545 Representations and Strategies for Recovery https://ClinicalTrials.gov/show/NCT03028545 Completed Hôpital le Vinatier 2019-09-30
NCT03011190 Effectiveness of the Iconic Therapy for Borderline Personality Disorder Symptoms https://ClinicalTrials.gov/show/NCT03011190 Completed University of Malaga 2017-07-31
NCT02988037 Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study https://ClinicalTrials.gov/show/NCT02988037 Completed University of Ottawa 2016-09-30
NCT02985047 Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide https://ClinicalTrials.gov/show/NCT02985047 Completed Region Skane 2018-06-30
NCT02935218 Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program https://ClinicalTrials.gov/show/NCT02935218 Completed Freie Universität Berlin 2015-04-30
NCT02866110 Training of Neural Responding in BPD https://ClinicalTrials.gov/show/NCT02866110 Completed Central Institute of Mental Health, Mannheim 2018-07-31
NCT02751632 The Staged Treatment in Early Psychosis Study https://ClinicalTrials.gov/show/NCT02751632 Active, not recruiting Orygen Youth Health Research Centre 2019-07-31
NCT02728778 Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD) https://ClinicalTrials.gov/show/NCT02728778 Completed Hannover Medical School 2019-04-30
NCT02574429 CPT Group for DBT Clients With Co-Occurring Borderline Personality Disorder and PTSD https://ClinicalTrials.gov/show/NCT02574429 Completed St. Joseph’s Healthcare Hamilton 2018-12-31
NCT02033044 Cognitive Rehabilitation Versus Psychoeducation in Psychosocial Functioning of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT02033044 Completed Hospital San Carlos, Madrid 2013-06-30
NCT02535156 Schizotypal Personality Disorder Risperidone https://ClinicalTrials.gov/show/NCT02535156 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2014-01-31
NCT02524899 CRT-Guanfacine for SPD https://ClinicalTrials.gov/show/NCT02524899 Completed Icahn School of Medicine at Mount Sinai 2017-01-10
NCT02524171 Justice-Involved Veterans and Moral Reconation Therapy https://ClinicalTrials.gov/show/NCT02524171 Active, not recruiting VA Office of Research and Development 2020-05-31
NCT02523664 Neural Correlates of Stress Hormones https://ClinicalTrials.gov/show/NCT02523664 Completed Charite University, Berlin, Germany 2018-12-31
NCT02518906 Evaluation of AIT Study https://ClinicalTrials.gov/show/NCT02518906 Active, not recruiting University Hospital, Basel, Switzerland 2019-09-30
NCT02517723 Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder https://ClinicalTrials.gov/show/NCT02517723 Active, not recruiting Evangelisches Krankenhaus Bielefeld gGmbH 2020-03-31
NCT02507206 A D1 Agonist For Working Memory https://ClinicalTrials.gov/show/NCT02507206 Completed Icahn School of Medicine at Mount Sinai 2018-01-12
NCT02465697 Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions https://ClinicalTrials.gov/show/NCT02465697 Completed Icahn School of Medicine at Mount Sinai 2017-09-21
NCT03387007 Psycho-social Support on Mental Health and Hope of Adolescents Affected by Earthquake in Nepal https://ClinicalTrials.gov/show/NCT03387007 Completed Tokyo University 2017-03-31
NCT02397031 Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT02397031 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2014-04-30
NCT02387736 DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical &Cost Effectiveness of a 6 mo. Treatment https://ClinicalTrials.gov/show/NCT02387736 Active, not recruiting Centre for Addiction and Mental Health 2019-07-31
NCT02370316 Biomarkers of Change in BPD After Metacognitive Interpersonal Therapy-standard Approach https://ClinicalTrials.gov/show/NCT02370316 Completed IRCCS Centro San Giovanni di Dio Fatebenefratelli 2018-11-30
NCT02276469 Peer Support for Severe Mental Disorders https://ClinicalTrials.gov/show/NCT02276469 Completed Universitätsklinikum Hamburg-Eppendorf 2014-11-30
NCT02273674 TMS in Borderline Personality Disorder Patients https://ClinicalTrials.gov/show/NCT02273674 Completed Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 2016-01-31
NCT02225600 The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults https://ClinicalTrials.gov/show/NCT02225600 Recruiting Icahn School of Medicine at Mount Sinai 2020-12-31
NCT02203708 Supportive Program for Mother With BPD https://ClinicalTrials.gov/show/NCT02203708 Completed University Hospital, Toulouse 2014-05-31
NCT02131883 Outcome of Cognitive Behavioral Therapy for Patients With Severe Health Anxiety Treated in Group Only. A RCT. https://ClinicalTrials.gov/show/NCT02131883 Completed Psychiatric Research Unit, Region Zealand, Denmark 2019-01-31
NCT02125942 Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment https://ClinicalTrials.gov/show/NCT02125942 Completed University of California, San Francisco 2015-09-30
NCT02097706 A Novel Drug for Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT02097706 Recruiting The Alfred 2020-12-31
NCT02068326 MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02068326 Completed Psychiatric Research Unit, Region Zealand, Denmark 2018-05-11
NCT01311193 Circadian Sleep-wake Cycles and Light Therapy in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT01311193 Completed University Hospital, Basel, Switzerland NA
NCT02005367 A Novel Person-Centered Treatment Component for Substance Use Treatment https://ClinicalTrials.gov/show/NCT02005367 Completed Hampton VA Medical Center 2011-12-31
NCT01986257 ERGT for Women Engaging in NSSI - an Effectiveness Study https://ClinicalTrials.gov/show/NCT01986257 Completed Karolinska Institutet 2014-07-31
NCT04432129 Integrated Mental Health Care and Vocational Rehabilitation to People With to Common Mental Disorders https://ClinicalTrials.gov/show/NCT04432129 Recruiting Mental Health Centre Copenhagen 2022-11-15
NCT01952405 Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT01952405 Completed Mackay Memorial Hospital 2017-02-24
NCT01912391 Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT01912391 Completed Mood and Anxiety Research, Inc 2015-03-31
NCT01896024 Effects of Motive-Oriented Therapeutic Relationship in the Early-Phase Treatment of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT01896024 Completed University of Lausanne Hospitals 2013-05-31
NCT01876524 tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients https://ClinicalTrials.gov/show/NCT01876524 Completed Spanish Foundation for Neurometrics Development 2014-08-31
NCT01719731 Psychoeducation of Borderline Patients https://ClinicalTrials.gov/show/NCT01719731 Completed Mclean Hospital 2015-04-30
NCT01653548 Evaluating a Novel Method of Generalizing Emotion Regulation https://ClinicalTrials.gov/show/NCT01653548 Completed Duke University 2016-05-31
NCT01512602 Efficacy of Dialectical Behavior Therapy Versus CAMS-informed Supportive Psychotherapy on Self Harming Behavior https://ClinicalTrials.gov/show/NCT01512602 Completed Mental Health Services in the Capital Region, Denmark 2014-07-31
NCT01428349 Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates https://ClinicalTrials.gov/show/NCT01428349 Completed University of Wisconsin, Madison 2013-05-31
NCT04318899 Predictors of Clinical Course and Treatment Response in DBT Programmes https://ClinicalTrials.gov/show/NCT04318899 Recruiting Oslo University Hospital 2022-12-31
NCT04296604 Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations https://ClinicalTrials.gov/show/NCT04296604 Recruiting Massachusetts General Hospital 2022-09-30
NCT04259554 OFC rTMS in Emotionally Unstable and Depressed Patients https://ClinicalTrials.gov/show/NCT04259554 Recruiting University of Regensburg 2020-10-01
NCT04244786 Treating Self Injurious Behavior: A Novel Brain Stimulation Approach https://ClinicalTrials.gov/show/NCT04244786 Recruiting New York State Psychiatric Institute 2021-10-31
NCT04211688 Effectiveness of a Combined Group-individual Schema Therapy for Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT04211688 Completed Consorci Sanitari del Maresme 2019-12-01
NCT04186403 Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT04186403 Recruiting Otsuka Pharmaceutical Development & Commercialization, Inc. 2021-04-30
NCT04169048 Parenting Skills for Mothers With Borderline Personality Disorder (BPD) https://ClinicalTrials.gov/show/NCT04169048 Recruiting Freie Universität Berlin 2022-06-30
NCT04160871 “Family Connections”: a Program for Relatives of People With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT04160871 Recruiting Universitat Jaume I 2020-09-30
NCT04100096 A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT04100096 Recruiting Otsuka Pharmaceutical Development & Commercialization, Inc. 2021-01-31
NCT03972735 Assessment of the Effectiveness of the NECT Program https://ClinicalTrials.gov/show/NCT03972735 Recruiting Hospital Center Alpes-Isère 2022-09-01
NCT03968081 Exploration of Theory of Mind in a Situation of Social Rejection in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03968081 Recruiting Versailles Hospital 2022-06-21
NCT03906435 Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial) https://ClinicalTrials.gov/show/NCT03906435 Recruiting University of Texas Southwestern Medical Center 2020-12-30
NCT03861858 Dialectical Behavior Therapy for Adolescents at Rutgers University https://ClinicalTrials.gov/show/NCT03861858 Recruiting Rutgers, The State University of New Jersey 2028-11-18
NCT03846375 Emotional Dysregulation in Para-suicidal Behavior https://ClinicalTrials.gov/show/NCT03846375 Recruiting Haukeland University Hospital 2025-01-02
NCT03833531 Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and CPD https://ClinicalTrials.gov/show/NCT03833531 Recruiting Arkin 2020-04-02
NCT03833453 Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and BPD https://ClinicalTrials.gov/show/NCT03833453 Recruiting Arkin 2020-04-02
NCT03832777 Transcranial Magnetic Stimulation on Dorsomedial Prefrontal Cortex in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03832777 Recruiting Universidad Autonoma de Queretaro 2019-01-30
NCT03776422 Homeless Youth Study - Stepping Stone 2.0 https://ClinicalTrials.gov/show/NCT03776422 Completed Rush University Medical Center 2019-07-08
NCT03717818 Mechanisms of Change in Brief Treatment for Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03717818 Recruiting University of Lausanne Hospitals 2022-12-31
NCT03681145 Youth to Text or Telehealth for Engagement in HIV Care https://ClinicalTrials.gov/show/NCT03681145 Completed University of California, San Francisco 2019-11-08
NCT03677037 The Short-Term MBT Project https://ClinicalTrials.gov/show/NCT03677037 Recruiting Mental Health Services in the Capital Region, Denmark 2021-04-01
NCT03665415 Expanded Game Squad for Neurodiverse Youth https://ClinicalTrials.gov/show/NCT03665415 Completed Merrimack College 2019-08-15
NCT03636139 Cognitive Control of Negative Stimuli in BPD https://ClinicalTrials.gov/show/NCT03636139 Completed Freie Universität Berlin 2017-06-30
NCT03630471 Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India https://ClinicalTrials.gov/show/NCT03630471 Completed Sangath 2019-01-20
NCT03602521 Reactivity of Patients With Borderline Personality Disorder to an Ecological Interpersonal Stress https://ClinicalTrials.gov/show/NCT03602521 Recruiting University Hospital, Montpellier 2021-05-27
NCT03418675 Brexpiprazole in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03418675 Recruiting University of Chicago 2020-07-31
NCT03418142 Evaluating an Internet-Based Self-Management Intervention for Borderline https://ClinicalTrials.gov/show/NCT03418142 Completed Gaia AG 2020-01-29
NCT01243658 “The Effects of Oxytocin on Patients With Borderline Personality Disorder” https://ClinicalTrials.gov/show/NCT01243658 Recruiting University of Freiburg 2020-12-31
NCT01193205 20 Weeks DBT Group Skills Training Study https://ClinicalTrials.gov/show/NCT01193205 Completed Centre for Addiction and Mental Health 2012-12-31
NCT01189812 Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms https://ClinicalTrials.gov/show/NCT01189812 Completed Columbia Northwest Pharmaceuticals 2011-01-31
NCT01133301 Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT01133301 Completed Central Institute of Mental Health, Mannheim 2001-08-31
NCT01132976 The Personal Concerns Inventory Study (PCI) https://ClinicalTrials.gov/show/NCT01132976 Completed Nottinghamshire Healthcare NHS Trust 2012-03-31
NCT01083823 Calling for Care: Cell Phones for Mood Telemetry in Teens https://ClinicalTrials.gov/show/NCT01083823 Completed Sunnybrook Health Sciences Centre 2012-04-30
NCT01081314 Treating PTSD in Patients With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT01081314 Completed University of Washington 2013-05-31
NCT01076933 Transcranial Magnetic Stimulation for Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT01076933 Completed University Hospital, Toulouse 2011-03-31
NCT00880919 Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD) https://ClinicalTrials.gov/show/NCT00880919 Completed University of Minnesota 2013-03-31
NCT00834834 Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00834834 Completed New York State Psychiatric Institute 2015-08-31
NCT03060902 Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03060902 Recruiting University of Oregon 2022-04-30
NCT02308462 Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents https://ClinicalTrials.gov/show/NCT02308462 Active, not recruiting Universitätsklinikum Hamburg-Eppendorf 2019-06-30
NCT03627663 DBT-SS for Cognitively Challenged Individuals With Deliberate Self-harm https://ClinicalTrials.gov/show/NCT03627663 Completed Region Skane 2020-04-01
NCT00714311 Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00714311 Completed University Hospital Muenster 2009-02-28
NCT00635921 Ziprasidone in the Treatment of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00635921 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2006-04-30
NCT00634062 Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00634062 Completed Mclean Hospital 2007-09-30
NCT00603421 Effectiveness of a 24 Hour Phone Line on the Rate of Suicide Attempts in Borderline Patients https://ClinicalTrials.gov/show/NCT00603421 Completed Assistance Publique - Hôpitaux de Paris 2014-10-31
NCT00538135 BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00538135 Completed University of Aberdeen NA
NCT00533117 Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00533117 Completed New York State Psychiatric Institute 2008-01-31
NCT00521417 Short- and Long-term Group Psychotherapy https://ClinicalTrials.gov/show/NCT00521417 Active, not recruiting University of Oslo 2018-08-31
NCT00467038 Treatment of Aggression, Anger and Emotional Dysregulation in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00467038 Completed VA Office of Research and Development 2010-09-30
NCT00458094 Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses https://ClinicalTrials.gov/show/NCT00458094 Completed Johns Hopkins University 2009-12-31
NCT00423462 First Experimental Study of Transference-Interpretations (FEST) https://ClinicalTrials.gov/show/NCT00423462 Completed University of Oslo NA
NCT00291031 Study of the Effect of Imagery Rehearsal Therapy (IRT) of Nightmares https://ClinicalTrials.gov/show/NCT00291031 Completed GGZ Centraal 2011-01-31
NCT00275301 PET Imaging and Olanzapine Treatment in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00275301 Completed University of Minnesota 2008-04-30
NCT00254748 Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients https://ClinicalTrials.gov/show/NCT00254748 Completed AstraZeneca NA
NCT00247234 Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders https://ClinicalTrials.gov/show/NCT00247234 Completed Norwegian University of Science and Technology 2011-06-30
NCT00222482 Depakote ER in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00222482 Completed University of Minnesota NA
NCT00204347 Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00204347 Completed University of Alabama at Birmingham 2007-10-31
NCT00202215 Chrysalis Day Program Body Mass Index Study https://ClinicalTrials.gov/show/NCT00202215 Completed Queen’s University NA
NCT00202202 User Satisfaction Survey - Personality Disorder Service https://ClinicalTrials.gov/show/NCT00202202 Completed Queen’s University NA
NCT00184301 A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder. https://ClinicalTrials.gov/show/NCT00184301 Completed Norwegian University of Science and Technology 2011-12-31
NCT00183651 Treatment of Suicidal Women With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00183651 Completed University of Washington 2008-09-30
NCT00178061 Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder https://ClinicalTrials.gov/show/NCT00178061 Completed University of Pittsburgh NA
NCT00158028 Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder https://ClinicalTrials.gov/show/NCT00158028 Completed Icahn School of Medicine at Mount Sinai 2001-12-31
NCT00154154 Hope for the Chronically Suicidal Patient https://ClinicalTrials.gov/show/NCT00154154 Completed Centre for Addiction and Mental Health 2007-06-30
NCT00153959 Psychiatric Day Hospital Treatment https://ClinicalTrials.gov/show/NCT00153959 Completed Technische Universität Dresden NA
NCT00145678 Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder https://ClinicalTrials.gov/show/NCT00145678 Completed State University of New York - Upstate Medical University 2010-05-31
NCT00137189 Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation https://ClinicalTrials.gov/show/NCT00137189 Completed NORCE Norwegian Research Centre AS 2010-10-31
NCT00122070 Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00122070 Completed Rutgers, The State University of New Jersey 2007-09-30
NCT00117741 Evaluation of DBT Compared to Drug Counseling for Opiate Addicts https://ClinicalTrials.gov/show/NCT00117741 Completed University of Washington 2008-10-31
NCT00091650 Olanzapine in Patients With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00091650 Completed Eli Lilly and Company NA
NCT00088036 Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00088036 Completed Eli Lilly and Company NA
NCT00055315 Treatment for Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00055315 Completed University of Iowa 2007-12-31
NCT00000376 Cognitive and Drug Therapy for Drug-Resistant Depression https://ClinicalTrials.gov/show/NCT00000376 Completed University of Pennsylvania NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03131505 INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1 https://ClinicalTrials.gov/show/NCT03131505 Completed Norfolk and Suffolk NHS Foundation Trust 2017-12-01
NCT03018639 Impact of Therapist Change on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving DBT https://ClinicalTrials.gov/show/NCT03018639 Completed Evangelisches Krankenhaus Bielefeld gGmbH 2016-08-31
NCT02829658 Use of Care Services by Patients With Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT02829658 Completed University Hospital, Toulouse 2010-06-30
NCT02755181 fMRI in Impulsivity https://ClinicalTrials.gov/show/NCT02755181 Completed Boehringer Ingelheim 2018-05-30
NCT02330614 Personality Bleaching https://ClinicalTrials.gov/show/NCT02330614 Completed University of Chile 2013-12-31
NCT02239055 Staff Nurse Perceptions of MBT Skills Training for Working With BPD in AMH https://ClinicalTrials.gov/show/NCT02239055 Completed University of Aberdeen 2014-08-31
NCT02055677 Personality Profiles, Values and Empathy: Differences Between Ovo/Lacto-vegetarians and Vegans https://ClinicalTrials.gov/show/NCT02055677 Completed Charite University, Berlin, Germany 2014-04-30
NCT01924715 Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study https://ClinicalTrials.gov/show/NCT01924715 Completed Nova Scotia Health Authority 2009-03-31
NCT01635556 Evaluation of a Modified Dialectical Behavior Therapy Program https://ClinicalTrials.gov/show/NCT01635556 Completed University of Manitoba 2016-01-31
NCT04304417 The Role of Group Identity on the Community Integration of People With Severe Mental Disorder https://ClinicalTrials.gov/show/NCT04304417 Recruiting Universidad Complutense de Madrid 2020-03-31
NCT04207970 Evaluating Adapted Structured Clinical Management for People With a Diagnosis of Personality Disorder https://ClinicalTrials.gov/show/NCT04207970 Active, not recruiting Camden and Islington NHS Trust 2020-06-01
NCT04157907 Reflective Functioning and Psychotherapy Processes in MBT https://ClinicalTrials.gov/show/NCT04157907 Recruiting Oslo University Hospital 2025-02-28
NCT04080141 Therapeutic Termination of Pregnancy and Psychiatric Implications https://ClinicalTrials.gov/show/NCT04080141 Completed University of Milano Bicocca 2016-12-31
NCT03968705 Longstanding Eating Disorders and Personality Disorders https://ClinicalTrials.gov/show/NCT03968705 Active, not recruiting Modum Bad 2021-01-31
NCT03932188 Brain Imaging in Early Psychosis https://ClinicalTrials.gov/show/NCT03932188 Recruiting Washington University School of Medicine 2021-04-30
NCT03897816 Maternal Psychopathology and Offspring Mental Health (PSI_PER) https://ClinicalTrials.gov/show/NCT03897816 Completed University of Milano Bicocca 2016-03-15
NCT03753737 Personality Disorders and Substance Use Disorders in a Sexual Context in the Man Having Sex With Other Men Population https://ClinicalTrials.gov/show/NCT03753737 Completed Hospices Civils de Lyon 2019-04-29
NCT03434457 Maternal Adversity, Vulnerability and Neurodevelopment https://ClinicalTrials.gov/show/NCT03434457 Completed Douglas Mental Health University Institute 2017-12-01
NCT00845455 Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals. https://ClinicalTrials.gov/show/NCT00845455 Completed Rambam Health Care Campus 2009-06-30
NCT01253993 Impaired Decision-making in Adolescents https://ClinicalTrials.gov/show/NCT01253993 Completed UMC Utrecht 2007-06-30
NCT02800681 Psychopathological Differences Between Asperger Syndrome and Schizotypal Disorder in an Adult Sample https://ClinicalTrials.gov/show/NCT02800681 Completed Mental Health Services in the Capital Region, Denmark 2018-12-31
NCT00666146 Familial Schizophrenia and Spectrum Personality Disorders https://ClinicalTrials.gov/show/NCT00666146 Active, not recruiting University of Maryland, Baltimore 2010-07-31
NCT00275288 MRI Imaging in Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT00275288 Completed University of Minnesota NA
NCT00264069 ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry https://ClinicalTrials.gov/show/NCT00264069 Completed Janssen-Cilag, S.A. NA
NCT00184418 The Immune System and Psychiatric Disorders https://ClinicalTrials.gov/show/NCT00184418 Completed Norwegian University of Science and Technology 2008-01-31
NCT00001233 Study of Children at Risk for Disruptive Behavior Disorders https://ClinicalTrials.gov/show/NCT00001233 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04256720 The Multi-Ethnic Lifestyle Study https://ClinicalTrials.gov/show/NCT04256720 Recruiting University of Leicester 2023-11-01